Polymorphism-based genomic instability assays and next-generation sequencing-based homologous recombination deficiency test

HIGHLIGHTS

• who: Telomeric-allelic imbalance number et al. from the Merck and Co, Inc, E Scott Ave, Rahway, NJ, USA have published the research work: polymorphism-based genomic instability assays and next-generation sequencing-based homologous recombination deficiency test, in the Journal: (JOURNAL)
• what: In the current study, common genomic metrics including HRD score as a continuous variable assessed by SNP genotyping assays (OncoScan; Infinium CytoSNP-850K) showed good correlation with the clinically validated HRD test metric. The study demonstrated that GC content correction had a significantly different effect on OncoScan and CytoSNP data; it also . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.